Questions: Hashimoto Thyroiditis: Autoimmune Destruction and Progressive Thyroid Failure

Question 1

A patient has a brief episode of palpitations, heat intolerance, and anxiety. Tests show elevated T4 and suppressed TSH. Six weeks later she presents fatigued and cold-intolerant with elevated TSH and strongly positive anti-TPO antibodies. What is the most likely explanation?

• A. She had Graves disease that spontaneously resolved and was replaced by a separate Hashimoto's diagnosis
• B. She experienced Hashitoxicosis — preformed thyroid hormone released from rupturing follicles — followed by progressive hypothyroidism as glandular capacity fell
• C. Her initial hyperthyroid phase was caused by excessive iodine intake that then normalized
• D. TSH suppression always precedes overt hypothyroidism in all autoimmune thyroid diseases

Answer: (B)

Hashitoxicosis is the transient hyperthyroid phase of Hashimoto's thyroiditis. As immune-mediated follicular destruction begins, ruptured follicles release stored T3/T4 into circulation, mimicking hyperthyroidism. Because this is a discharge of preformed hormone — not autonomous gland overactivity — it is self-limited; once the hormone store is exhausted and follicular capacity declines, the patient becomes hypothyroid. The anti-TPO antibodies confirm the autoimmune etiology throughout. Option A (Graves disease) is driven by TSH-receptor stimulating antibodies, not anti-TPO.

Question 2

In Hashimoto thyroiditis, the earliest biochemical abnormality detectable on standard thyroid function testing is:

• A. A fall in free T4 below the normal reference range
• B. A rise in TSH above the normal range before T4 falls — the subclinical hypothyroid phase
• C. T3 toxicosis due to preferential T3 secretion from stressed follicular cells
• D. Anti-Tg antibodies rising above anti-TPO antibodies as the first marker

Answer: (B)

Because of the exquisitely sensitive negative-feedback loop between thyroid hormone and the pituitary, TSH rises before T4 actually falls below normal. This subclinical hypothyroid phase (elevated TSH, normal T4) can persist for years and is the earliest detectable biochemical signal of thyroid failure. Identifying it early — in a patient with positive anti-TPO antibodies — allows levothyroxine replacement before the physiological burden of chronic hypothyroidism accumulates.

Question 3

Anti-TPO antibodies are specific markers of Hashimoto thyroiditis because they target the enzyme directly responsible for incorporating iodine into thyroid hormone precursors.

• T. True
• F. False

Answer: True

Thyroid peroxidase (TPO) is the enzyme that oxidizes iodide to iodine during thyroid hormone synthesis — a mechanistically central step. Anti-TPO antibodies (present in >90% of Hashimoto patients) bind this specific target, fix complement, and recruit NK cells, contributing to follicular destruction via antibody-dependent cellular cytotoxicity. The antibody specificity reflects the immune attack on the gland's hormonal machinery, not a generic autoimmune response.

Question 4

The hypothyroid symptoms of Hashimoto thyroiditis appear suddenly once immune destruction crosses a critical threshold of follicular loss.

• T. True
• F. False

Answer: False

The clinical progression is gradual and staged, not sudden. TSH rises first (subclinical hypothyroid phase, potentially lasting years), before T4 falls and before symptoms appear. Overt hypothyroidism develops as follicular mass decreases further; myxedema represents end-stage untreated disease. The staged progression is clinically important because it means monitoring TSH in at-risk patients (positive anti-TPO antibodies) allows detection and treatment well before symptomatic onset.

Question 5

Why does Hashimoto thyroiditis sometimes cause brief hyperthyroid symptoms early in its course, even though the disease ultimately causes hypothyroidism?

Model answer: In early Hashimoto's, immune-mediated destruction causes thyroid follicles to rupture, releasing preformed T3/T4 stored inside them into the bloodstream. This sudden surge produces transient Hashitoxicosis with hyperthyroid symptoms (palpitations, heat intolerance, anxiety). As the stored hormone is exhausted and follicular capacity declines further, the patient transitions into hypothyroidism.

Hashitoxicosis is clinically important because it can be misdiagnosed as Graves disease, which requires different treatment. Key distinguishing features: (1) Hashitoxicosis is brief and self-limited (discharge of stored hormone, not autonomous overproduction); (2) Graves disease is driven by TSH-receptor stimulating antibodies; (3) anti-TPO/anti-Tg antibodies confirm Hashimoto's. Misdiagnosis could lead to inappropriate radioactive iodine ablation of a gland already failing.